These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6989494)

  • 41. Metabolism and macromolecular binding of carcinogenic and noncarcinogenic metabolites of benzo(a)pyrene by hamster embryo cells.
    Cohen GM; MacLeod MC; Moore CJ; Selkirk JK
    Cancer Res; 1980 Feb; 40(2):207-11. PubMed ID: 7356503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microsomal biotransformation of benzo[ghi]perylene, a mutagenic polycyclic aromatic hydrocarbon without a "classic" bay region.
    Platt KL; Grupe S
    Chem Res Toxicol; 2005 Apr; 18(4):700-10. PubMed ID: 15833030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons.
    Slaga TJ; Gleason GL; Mills G; Ewald L; Fu PP; Lee HM; Harvey RG
    Cancer Res; 1980 Jun; 40(6):1981-4. PubMed ID: 7371034
    [No Abstract]   [Full Text] [Related]  

  • 45. Stable expression of rat sulfotransferase 1B1 in V79 cells: activation of benzylic alcohols to mutagens.
    Teubner W; Meinl W; Glatt H
    Carcinogenesis; 2002 Nov; 23(11):1877-84. PubMed ID: 12419836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
    Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K
    Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steric crowding and conformer stability of the diol-epoxides of benzo(c)phenanthrene.
    Silverman BD
    Cancer Biochem Biophys; 1982; 6(1):23-9. PubMed ID: 7093935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterization of mutation and comparison of mutation profiles in the hprt gene of Chinese hamster ovary cells treated with benzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, 1-nitrobenzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, and 3-nitrobenzo[a]pyrene trans-7,8- diol-anti-9,10-epoxide.
    Zhan DJ; Heflich RH; Fu PP
    Environ Mol Mutagen; 1996; 27(1):19-29. PubMed ID: 8625944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutagenicity of polycyclic hydrocarbons. II. Monitoring genetical hazards of chrysene in vitro and vivo.
    Basler A; Herbold B; Peter S; Röhrborn G
    Mutat Res; 1977 Apr; 48(2):249-54. PubMed ID: 327309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of (-)-trans-(3R, 4R)-dihydroxy-3,4-dihydrochrysene to diol epoxides by liver microsomes.
    Vyas KP; Yagi H; Levin W; Conney AH; Jerina DM
    Biochem Biophys Res Commun; 1981 Feb; 98(4):961-9. PubMed ID: 7225135
    [No Abstract]   [Full Text] [Related]  

  • 51. Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene.
    Hecht SS; el-Bayoumy K; Rivenson A; Amin S
    Cancer Res; 1994 Jan; 54(1):21-4. PubMed ID: 8261440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutagenicity, tumor-initiating activity, and metabolism of methylphenanthrenes.
    LaVoie EJ; Tulley-Freiler L; Bedenko V; Hoffman D
    Cancer Res; 1981 Sep; 41(9 Pt 1):3441-7. PubMed ID: 7020927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
    Vyas KP; Levin W; Yagi H; Thakker DR; Ryan DE; Thomas PE; Conney AH; Jerina DM
    Mol Pharmacol; 1982 Jul; 22(1):182-9. PubMed ID: 7121449
    [No Abstract]   [Full Text] [Related]  

  • 54. Synthesis and mutagenicity of modified chrysenes related to the carcinogen, 5-methylchrysene.
    Hecht SS; Loy M; Mazzarese R; Hoffmann D
    J Med Chem; 1978 Jan; 21(1):38-44. PubMed ID: 338903
    [No Abstract]   [Full Text] [Related]  

  • 55. [Selective inhibition of the fluorescence of benzo(a)pyrene and a mutagenic diol-epoxide derivative in living cells by liposoluble iodinated hydrocarbons].
    Deumié M; Bartholomew JC; Wade CG
    C R Seances Acad Sci D; 1980 Jun; 290(22):1417-20. PubMed ID: 6772331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic activation of 3-methylcholanthrene and benzo(a)pyrene to mutagens in the L5178Y/TK assay by cultured embryonic rodent cells.
    Amacher DE; Paillet SC; Zelljadt I
    Environ Mutagen; 1982; 4(2):109-19. PubMed ID: 7075576
    [No Abstract]   [Full Text] [Related]  

  • 57. Electronic structure and reactivity of four stereo isomers of benzo(a)pyrene 7,8-diol-9,10-epoxide.
    Kikuchi O; Hopfinger AJ; Klopman G
    Cancer Biochem Biophys; 1979; 4(1):1-8. PubMed ID: 498059
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of antioxidants on the yield of gene mutations induced by benzo(a)pyrene in mammalian cells in vitro].
    Pashin IuV; Bakhitova LM
    Biull Eksp Biol Med; 1983 Mar; 95(3):69-70. PubMed ID: 6830990
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluorescence spectral studies on the metabolic activation of chrysene by hamster embryo cells.
    Vigny P; Spiro M; Hodgson RM; Grover PL; Sims P
    Carcinogenesis; 1982; 3(12):1491-3. PubMed ID: 7151264
    [No Abstract]   [Full Text] [Related]  

  • 60. Double-stranded DNA steroselectively binds benzo(a)pyrene diol epoxides.
    Meehan T; Straub K
    Nature; 1979 Feb; 277(5695):410-2. PubMed ID: 551262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.